MedPath

Psychometric Characterization of Patients With Cardiac Arrhythmias

Conditions
Cardiac Arrhythmia
Personality
Psychological Stress
Anxiety
Depression
Registration Number
NCT04474418
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

To investigate the influence of different psychological parameters (e.g. depression, anxiety, personality traits, resilience, tolerance of uncertainty or heart beat perception) on treatment outcome and quality of life in patients with cardiac arrythmias.

Detailed Description

This longitudinal observational study examines patients with cardiac arrhythmia (such as atrial fibrillation or atrial flutter) who are undergoing a conventional standard therapy in the Department of Cardiology of the Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin. To examine the impact of psychological symptoms such as anxiety, depression, resilience and risk factors (e.g. neuroticism) on cardiac treatment outcomes, patients are evaluated with a standardized psychological assessment including established questionnaires. The baseline observation is performed before the standard treatment of the arrhythmia (e.g. pharmacological treatment or electrophysiological methods). Follow-up observations are made 3 and 6 month after the cardiological intervention.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Age of majority (min. 18 years old)
  • no severe cognitive dysfunction
  • diagnosed cardiac arrhythmias
  • reason of admission is the treatment of cardiac arrhythmia
Exclusion Criteria
  • medium to severe cognitive dysfunction
  • doubt on capacity to give consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Beck Depression Inventory (BDI) - Change from Baseline at 6 monthsFrom Baseline at 6 months (Follow-up) after standard therapy

BDI is a questionnaire measuring depression

Secondary Outcome Measures
NameTimeMethod
Anxiety Sensitivity Index (ASI) - Baseline Anxiety Sensitivity Index (ASI)Baseline

ASI is a Questionnaire measuring anxiety sensitivity

NEO-FFI personality inventoryOnly at baseline

personality inventory measuring neuroticism, extraversion, openness to experience, agreeableness, conscientiousness

Electrocardiography (ECG) - Change from Baseline at 6 monthsFrom Baseline at 6 months (Follow-up) after standard therapy

measuring heart activity and signs of cardiac arrhythmias

Angstkontrollfragebogen (AKF) - 6 months after standard therapy6 months after standard therapy

AKF is the German Version of the Anxiety Control Questionnaire

Resilienzskala (RS-13) - 3 months after standard therapy3 months after standard therapy

Questionnaire to measure resilience

Skala zur allgemeinen Selbstwirksamkeitserwartung (SWE) - 6 months after standard therapy6 months after standard therapy

Questionnaire to measure self-efficacy

ICD-10-Symptom-Rating (ISR) - Change from Baseline at 6 monthsFrom Baseline at 6 months after standard therapy

Questionnaire to assess symptoms of psychiatric disorders

Perceived Stress Questionnaire (PSQ) - Change from Baseline at 6 monthsFrom Baseline at 6 months after standard therapy

Questionnaire to measure psychological stress perception

Euroquol EQ-5D-3L - Change from Baseline at 6From Baseline at 6 months after standard therapy

Questionnaire to measure quality of life

Heart beat Counting Task by SchandryBaseline

Assessment of patients heart beat perception

Angstkontrollfragebogen (AKF) - BaselineBaseline before standard therapy

AKF is the German Version of the Anxiety Control Questionnaire

Angstkontrollfragebogen (AKF) - 3 months after standard therapy3 months after standard therapy

AKF is the German Version of the Anxiety Control Questionnaire

Beck Anxiety Inventory (BAI) - Change from Baseline at 6 monthsFrom Baseline at 6 months (Follow-up) after standard therapy

BAI is a questionnaire measuring anxiety

Heart rate variability - BaselineBaseline before standard therapy

heart rate variability is a non-invasive method to measure autonomic nervous system function

Resilienzskala (RS-13) - BaselineBaseline

Questionnaire to measure resilience

Resilienzskala (RS-13) - 6 months after standard therapy6 months after standard therapy

Questionnaire to measure resilience

Skala zur allgemeinen Selbstwirksamkeitserwartung (SWE) - BaselineBaseline

Questionnaire to measure self-efficacy

Anxiety Sensitivity Index (ASI) - 3 months after standard therapy Anxiety Sensitivity Index (ASI)3 months after standard therapy

ASI is a Questionnaire measuring anxiety sensitivity

Heart rate variability - 3 months after standard therapy3 months after standard therapy

heart rate variability is a non-invasive method to measure autonomic nervous system function

Skala zur allgemeinen Selbstwirksamkeitserwartung (SWE) - 3 months after standard therapy3 months after standard therapy

Questionnaire to measure self-efficacy

Anxiety Sensitivity Index (ASI) - 6 months after standard therapy Anxiety Sensitivity Index (ASI)6 months after standard therapy

ASI is a Questionnaire measuring anxiety sensitivity

Heart rate variability - 6 months after standard therapy6 months after Standardtherapie

heart rate variability is a non-invasive method to measure autonomic nervous system function

Body Sensations Questionnaire (BSQ) - Change from Baseline at 6 monthsFrom Baseline at 6 months after standard therapy

Questionnaire to measure body sensations related to anxiety

Herzangstfragebogen (HAF-17) - Change from Baseline at 6From Baseline at 6 months after standard therapy

Questionnaire to measure anxiety with respect to cardiac symptoms

Fragebogen zu Akzeptanz und Handeln II (FAH-II) - Change from Baseline at 6 monthsFrom Baseline at 6 months after standard therapy

Questionnaire to measure psychological flexibility

Unsicherheitsintoleranzfragebogen (UI-18)Baseline

Questionnaire to measure tolerance to uncertainty

Trial Locations

Locations (1)

Charité - Universitätsmedizin Berlin

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath